Duracoll

Duracoll, containing Gentamicin, is an implantable pharmaceutical used for localized antibiotic treatment. It is manufactured by Serb Sa and originates from the EU.

Duracoll is designed for localized antibiotic therapy, often used in surgical procedures to prevent or treat infections. It is implanted directly at the site of concern, providing targeted action. The primary use of Gentamicin in Duracoll is to address bacterial infections in specific areas, such as during orthopedic surgeries.

Duracoll works by delivering Gentamicin directly to the affected area, which may help in reducing bacterial growth. Common effects include localized relief from infection-related symptoms, though individual responses can vary.

Duracoll should be handled with care, ensuring proper sterile techniques during implantation. It is important to follow healthcare provider instructions regarding its use. Patients with known allergies to Gentamicin or similar antibiotics should inform their healthcare provider before use.

Duracoll may interact with other medications, particularly those that affect kidney function or other antibiotics. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.